Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.7K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.7K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

810
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
810
Bacterial Phylum Spirochaetes01:30

Bacterial Phylum Spirochaetes

1.5K
Spirochetes, unique bacteria in the phylum Spirochaetes, are gram-negative, motile, tightly coiled, slender, and flexible. They inhabit aquatic sediments and animals, with some causing diseases like syphilis. Spirochetes are classified into eight genera based on habitat, pathogenicity, phylogeny, and characteristics.Their distinctive motility arises from endoflagella, located within the cell’s periplasm. These endoflagella anchor at the cell poles and extend along the cell length, encased...
1.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

984
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
984
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Update on the comparative <i>in vitro</i> activity of cefiderocol and four β-lactam-β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens.

JAC-antimicrobial resistance·2026
Same author

Multicenter Evaluation of the Novel ETEST Fosfomycin for Antimicrobial Susceptibility Testing of Enterobacterales, Enterococcus faecalis, and Staphylococcus Species.

Journal of clinical microbiology·2022
Same author

Effect of ampC derepression on cefepime MIC in Enterobacterales with chromosomally encoded inducible AmpC β-lactamase.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Evaluation of six commercial products for colistin susceptibility testing in Enterobacterales.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Comparison of five methods for detection of carbapenemases in Enterobacterales with proposal of a new algorithm.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Empirical treatment of lower urinary tract infections in the face of spreading multidrug resistance: in vitro study on the effectiveness of nitroxoline.

International journal of antimicrobial agents·2017

Related Experiment Video

Updated: Apr 28, 2026

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis
06:09

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis

Published on: September 30, 2017

6.3K

[Tularemia in Germany].

R Kohlmann1, G Geis1, S G Gatermann1

  • 1Institut für Medizinische Laboratoriumsdiagnostik (IML) Bochum GmbH.

Deutsche Medizinische Wochenschrift (1946)
|June 18, 2014
PubMed
Summary

Tularemia, caused by Francisella tularensis, is a rare zoonotic disease in Germany with diverse symptoms. Early diagnosis and treatment are challenging due to low prevalence and nonspecific signs.

Area of Science:

  • Infectious Diseases
  • Bacteriology
  • Epidemiology

Context:

  • Francisella tularensis causes tularemia, a zoonotic disease prevalent globally in the Northern Hemisphere.
  • Tularemia is infrequently observed in Germany, complicating early diagnosis.
  • The disease presents with varied clinical manifestations, including ulceroglandular, glandular, and respiratory forms.

Purpose:

  • To provide a comprehensive overview of tularemia, focusing on its status in Germany.
  • To summarize current knowledge on the etiology, ecology, and transmission of Francisella tularensis.
  • To detail the clinical presentation, diagnostic methods, and treatment strategies for tularemia.

Summary:

  • This review covers the etiology, ecology, transmission, epidemiology, clinical features, diagnostics, and treatment of tularemia.

More Related Videos

Feeding of Ticks on Animals for Transmission and Xenodiagnosis in Lyme Disease Research
08:23

Feeding of Ticks on Animals for Transmission and Xenodiagnosis in Lyme Disease Research

Published on: August 31, 2013

12.8K
Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
10:05

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

15.8K

Related Experiment Videos

Last Updated: Apr 28, 2026

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis
06:09

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis

Published on: September 30, 2017

6.3K
Feeding of Ticks on Animals for Transmission and Xenodiagnosis in Lyme Disease Research
08:23

Feeding of Ticks on Animals for Transmission and Xenodiagnosis in Lyme Disease Research

Published on: August 31, 2013

12.8K
Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
10:05

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

15.8K
  • Emphasis is placed on the specific situation regarding tularemia in Germany, highlighting its low prevalence and diagnostic challenges.
  • The article synthesizes information on the diverse clinical forms of tularemia and the importance of timely intervention.

    • Impact:

    • Aims to improve understanding and management of tularemia, particularly in regions with low incidence.
    • Provides a valuable resource for clinicians and public health officials dealing with rare infectious diseases.
    • Facilitates earlier diagnosis and more effective treatment of tularemia by consolidating key information.